S. Iimura, W. Wu / Tetrahedron Letters 51 (2010) 1353–1355
1355
Pinacol + BH3-PhNEt2
dioxane
oC to rt
O
0
O
OMe
NHBoc
Pinacolborane (2 equiv)
PdCl2(dppf) (0.5 mol%)
OMe
NHBoc
O
B
NMM
Dioxane, 80 °C
TfO
O
1a
2a
82%
Scheme 2. Borylation using pinacolborane prepared in situ.
Barnum, B. A.; Rong, F.-G.; Barth, R. F.; Codogni, I. M.; Wilson, J. G. Chem. Rev.
1998, 98, 1515; (d) Barth, R. F.; Coderre, J. A.; Vicente, M. G. H.; Blue, T. E. Clin.
Cancer Res. 2005, 11, 3987; (e) Yamamoto, T.; Nakai, K.; Matsumura, A. Cancer
Lett. 2008, 262, 143.
acolboron or the hydrogen atom can be transferred to give species
6 and 7, respectively, which upon fast reductive eliminations result
in borylation product 8 and reduction product 9, respectively. We
propose that the bases employed in this reaction may form com-
plexes 10 and 11 with pinacolborane depending on the Lewis basi-
city of the bases employed. A weakly coordinating Lewis base, such
as trialkylamines, likely forms the weakly bound complex 10
whereas a strongly coordinating Lewis base, such as DABCO and
DMAP, likely forms the strongly bound complex 11. Due to the
oxophilic nature of boron, the oxygen-centered bases possibly also
form the strongly bound complex 11. The weakly bound complex
10 activates the borylation pathway, whereas the strongly bound
‘ate’ complex 11 prefers the hydride transfer pathway.17 This
mechanism is consistent with the results summarized in Table 2.
In order to further improve the efficiency of the reaction for
large-scale manufacture, it was carried out using pinacolborane
prepared in situ (Scheme 2). The less active and more stable bor-
ane–diethylaniline complex was shown to be optimal for this pin-
acolborane preparation.18 The reaction proceeded to give 2a in 82%
isolated yield.
4. (a) Roberts, D. C.; Suda, K.; Samanen, J.; Kemp, D. S. Tetrahedron Lett. 1980, 21,
3435; (b) Samanen, J.; Cash, T.; Narindray, D.; Brandeis, E.; Yellin, T.; Regoli, D. J.
Med. Chem. 1989, 32, 1366; (c) Duggan, P. J.; Offermann, D. A. Aust. J. Chem.
2007, 60, 829.
5. For examples, see: (a) Firooznia, F.; Gude, C.; Chan, K.; Marcopulos, N.; Satoh, Y.
Tetrahedron Lett. 1999, 40, 213; (b) Jung, M. E.; Lazarova, T. I. J. Org. Chem. 1999,
64, 2976; (c) Decicco, C. P.; Song, Y.; Evans, D. A. Org. Lett. 2001, 3, 1029; (d)
Deng, H.; Jung, J.-K.; Liu, T.; Kuntz, K. W.; Snapper, M. L.; Hoveyda, A. H. J. Am.
Chem. Soc. 2003, 125, 9032; (e) Skaff, O.; Jolliffe, K. A.; Hutton, C. A. J. Org. Chem.
2005, 70, 7353; (f) Takahashi, K.; Nakamura, H.; Furumoto, S.; Yamamoto, K.;
Fukuda, H.; Matsumura, A.; Yamamoto, Y. Bioorg. Med. Chem. 2005, 13, 735; (g)
Combs, A. P.; Zhu, W.; Crawley, M. L.; Glass, B.; Polam, P.; Sparks, R. B.; Modi,
D.; Takvorian, A.; McLaughlin, E.; Yue, E. W.; Wasserman, Z.; Bower, M.; Wei,
M.; Rupar, M.; Ala, P. J.; Reid, B. M.; Ellis, D.; Gonneville, L.; Emm, T.; Taylor, N.;
Yeleswaram, S.; Li, Y.; Wynn, R.; Burn, T. C.; Hollis, G.; Liu, P. C. C.; Metcalf, B. J.
Med. Chem. 2006, 49, 3774; (h) Gong, Y.; Barbay, J. K.; Dyatkin, A. B.; Miskowski,
T. A.; Kimball, E. S.; Prouty, S. M.; Fisher, M. C.; Santulli, R. J.; Schneider, C. R.;
Wallace, N. H.; Ballentine, S. A.; Hageman, W. E.; Masucci, J. A.; Maryanoff, B. E.;
Damiano, B. P.; Andrade-Gordon, P.; Hlasta, D. J.; Hornby, P. J.; He, W. J. Med.
Chem. 2006, 49, 3402; (i) Nambo, M.; Noyori, R.; Itami, K. J. Am. Chem. Soc. 2007,
129, 8080; (j) Gong, Y.; Barbay, J. K.; Kimball, E. S.; Santulli, R. J.; Fisher, M. C.;
Dyatkin, A. B.; Miskowski, T. A.; Hornby, P. J.; He, W. Bioorg. Med. Chem. Lett.
2008, 18, 1331.
In conclusion, an efficient borylation of a tyrosine triflate was
achieved with the use of the inexpensive pinacolborane reagent
in excellent yields and without racemization. Contrary to the pre-
vious reports, modified Masuda conditions were sufficient to
achieve satisfactory results. The catalyst loading can be reduced
to as low as 0.5 mol %. Additionally, the borylation can be carried
out using pinacolborane prepared in situ from borane–diethylani-
line complex, further reducing the cost. This work provides a prac-
tical and concise synthesis of protected 4-boronophenylalanine,
which can be either used directly as a building block in Suzuki cou-
6. (a) Samsel, E. G. U.S. Patent 5,157,149, 1992; (b) Kirihara, M.; Morimoto, T.;
Ichimoto, I. Biosci. Biotech. Biochem. 1993, 57, 1940; (c) Nakao, H.; Morimoto, T.;
Kirihara, M. Biosci. Biotech. Biochem. 1996, 60, 683; (d) Malan, C.; Morin, C.
Synlett 1996, 167; (e) Satoh, Y.; Gude, C.; Chan, K.; Firoozia, F. Tetrahedron Lett.
1997, 38, 7645; (f) Nakamura, H.; Fujiwara, M.; Yamamoto, Y. J. Org. Chem.
1998, 63, 7529; (g) Malan, C.; Morin, C. J. Org. Chem. 1998, 63, 8019; (h)
Nakamura, H.; Fujiwara, M.; Yamamoto, Y. Bull. Chem. Soc. Jpn. 2000, 73, 231; (i)
Zhu, W.; Ma, D. Org. Lett. 2006, 8, 261.
7. (a) Ishiyama, T.; Murata, M.; Miyaura, N. J. Org. Chem. 1995, 60, 7508; (b)
Ishiyama, T.; Itoh, Y.; Kitano, T.; Miyaura, N. Tetrahedron Lett. 1997, 38, 3447.
8. (a) Murata, M.; Watanabe, S.; Masuda, Y. J. Org. Chem. 1997, 62, 6458; (b)
Murata, M.; Oyama, T.; Watanabe, S.; Masuda, Y. J. Org. Chem. 2000, 65, 164.
9. For other examples of Pd-catalyzed borylation of aryl triflates with
pinacolborane, see: (a) Penhoat, M.; Levacher, V.; Dupas, G. J. Org. Chem.
2003, 68, 9517; (b) Brimble, M. A.; Lai, M. Y. H. Org. Biomol. Chem.
2003, 1, 2084; (c) Thompson, A. L. S.; Kabalka, G. W.; Akula, M. R.;
Huffman, J. W. Synthesis 2005, 547; (d) Altemöller, M.; Podlech, J.;
Fenske, D. Eur. J. Org. Chem. 2006, 1678; (e) Tam, V. K.; Liu, Q.; Tor, Y.
Chem. Commun. 2006, 2684; (f) Ahmed, V.; Liu, Y.; Silvestro, C.; Taylor,
S. D. Bioorg. Med. Chem. 2006, 14, 8564.
pling reactions or converted to L
-BPA using known procedures.6g
Acknowledgment
The authors are grateful to Lexicon’s analytical chemistry group
for their assistance in HPLC and LC–MS.
10. For a recent review, see: Ishiyama, T.; Miyaura, N. Chem. Rec. 2004, 3, 271.
11. Triflate 1a was prepared according to a literature procedure: Shieh, W.-C.;
Carlson, J. A. J. Org. Chem. 1992, 57, 379.
Supplementary data
12. Rosen, B. M.; Huang, C.; Percec, V. Org. Lett. 2008, 10, 2597.
13. For the latest deoxygenation methods of phenols, see: (a) Sajiki, H.; Mori, A.;
Mizusaki, T.; Ikawa, T.; Maegawa, T.; Hirota, K. Org. Lett. 2006, 8, 987; (b) Mori,
A.; Mizusaki, T.; Ikawa, T.; Maegawa, T.; Monguchi, Y.; Sajiki, H. Tetrahedron
2007, 63, 1270.
14. Broutin, P.-E.; Cerna, I.; Campaniello, M.; Leroux, F.; Colobert, F. Org. Lett. 2004,
6, 4419.
15. Further reduction in catalyst charge to 0.3 mol % afforded unsatisfactory
yields.
General methods, typical borylation procedure, preparative pro-
cedure of 1a, copies of 1H and 13C NMR spectra of compounds 1a,
2a, and 3, and chiral HPLC chromatograms for 2a are available.
Supplementary data associated with this article can be found, in
16. Recently, a Miyaura–Masuda borylation of aryl halides using low catalyst
loading was reported, see: Billingsley, K. L.; Buchwald, S. L. J. Org. Chem. 2008,
73, 5589.
17. Indeed, metal borohydride is known to reduce halides and sulfonates in the
presence of a palladium catalyst. See: (a) Egli, R. A. Helv. Chim. Acta 1968, 51,
2090; (b) Hutchins, R. O.; Learn, K. J. Org. Chem. 1982, 47, 4380.
18. (a) Tucker, C. E.; Davidson, J.; Knochel, P. J. Org. Chem. 1992, 57, 3482; (b)
Kikuchi, T.; Nobuta, Y.; Umeda, J.; Yamamoto, Y.; Ishiyama, T.; Miyaura, N.
Tetrahedron 2008, 64, 4967. and references therein.
References and notes
1. Snyder, H. R.; Reedy, A. J.; Lennarz, W. J. J. Am. Chem. Soc. 1958, 80, 835.
2. For preparation of 10B-enriched
L-BPA, see: Hattori, Y.; Asano, T.; Kirihata, M.;
Yamaguchi, Y.; Wakamiya, T. Tetrahedron Lett. 2008, 49, 4977. and references
therein.
3. For reviews, see: (a) Hawthorn, M. F. Angew. Chem., Int. Ed. Engl. 1993, 32, 950;
(b) Morin, C. Tetrahedron 1994, 50, 12521; (c) Soloway, A. H.; Tjarks, W.;